March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial intelligence (AI) tool that enhances pathology workflows by analysing whole ...

The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to ...

The core of NIH’s AI push is to break down data silos that limit how quickly researchers can respond to emerging public ...

Pregnant women in the United States are routinely tested for gestational diabetes, a condition where the body has high blood ...

Techcyte is pleased to announce that a validation study conducted by the Contra Costa County Public Health Laboratory (CCPHL) evaluating its AI-assisted ova and parasite (O&P) workflow has been ...

Drug Farm today announced ophthalmologic and central nervous system (CNS) findings from its Phase 1b study of DF-003, a first ...

Getting life insurance after cancer depends on the cancer type, grade, treatment and timing ...

Elevated NfL levels tracked with poorer cognitive scores and higher death risk in centenar ...